stockrowMaravai LifeSciences Holdings, Inc. (MRVI) vs Sarepta Therapeutics, Inc. (SRPT)
- Maravai LifeSciences Holdings, Inc. MRVI 7.52 +7.74%
- Sarepta Therapeutics, Inc. SRPT 17.71 +0.80%
Maravai LifeSciences Holdings, Inc. and Sarepta Therapeutics, Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and Sarepta Therapeutics, Inc. are of similar size ($1.9B and $1.8B). Maravai LifeSciences Holdings, Inc. grew revenue faster over the last twelve months: 10.7% against −19.0%. Sarepta Therapeutics, Inc. has the higher net margin (−5.86% vs −30.8%) and the higher return on invested capital (−2.03% vs −13.6%). Across the 18 metrics below, Sarepta Therapeutics, Inc. leads on 11 and Maravai LifeSciences Holdings, Inc. on 7.
Valuation
Profitability
| Metric | MRVI | SRPT | Biotechnology median |
|---|---|---|---|
| Gross margin | 39.15% | 0.00% | 68.51% |
| Operating margin | (45.38%) | (2.50%) | 0.00% |
| Net margin | (30.83%) | (5.86%) | 0.00% |
| Free cash flow margin | (5.89%) | 9.02% | 0.00% |
| Return on equity | (17.01%) | (8.05%) | (51.96%) |
| Return on assets | (9.06%) | (3.44%) | (46.06%) |
| Return on invested capital | (13.62%) | (2.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack